Evidence map›Paper›PMID 21179568›Full record

ArticlePloS one2010

A transient transgenic RNAi strategy for rapid characterization of gene function during embryonic development.

Bryan C Bjork, Yuko Fujiwara, Shannon W Davis, Haiyan Qiu, Thomas L Saunders, Peter Sandy, Stuart Orkin, Sally A Camper, David R Beier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Redundant roles of PRDM family members in zebrafish craniofacial development.Developmental dynamics : an official publication of the American Association of Anatomists · 2013
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Bryan C BjorkGenetics Division, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Yuko Fujiwara
Shannon W Davis
Haiyan Qiu
Thomas L Saunders
Peter Sandy
Stuart Orkin
Sally A Camper
David R Beier
Harvard University · USMichigan United · USBrigham and Women's Hospital · USMassachusetts Institute of Technology · USUniversity of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
University of Michigan Center for Gastrointestinal ResearchP30DK034933 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OWYANG, CHUNG · 1986 to 2021
$22.5M
Research DevelopmentP30AG013283 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MILLER, RICHARD A · 1995 to 2014
$12.3M
Mutagenesis and Murine Embyonic DevelopmentR01HD036404 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI BEIER, DAVID R. · 1998 to 2020
$8.1M
CELL-SPECIFIC EXPRESSION IN THE PITUITARY GLANDR01HD034283 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAMPER, SALLY A. · 1996 to 2021
$7.7M
A Panhypopitutitary Mouse MutationR37HD030428 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAMPER, SALLY A. · 2002 to 2011
$3.4M
UNIVERSITY OF MICHIGAN MULTIPURPOSE ARTHRITIS CENTERP60AR020557 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SOWERS, MARYFRAN R · 1986 to 2001
$2.9M
Analysis of neurodevelopment using mouse mutagenesisR01MH081187 · NIMH · SEATTLE CHILDREN'S HOSPITAL · PI BEIER, DAVID R. · 2008 to 2012
$2.4M
Harvard-SDM/Forsyth Scholar/Faculty Development ProgramK12DE014528 · NIDCR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STASHENKO, PHILIP · 2002 to 2006
$2.0M
Characterization of the Mouse cpo1 MutationF32HD045066 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI BJORK, BRYAN CARY · 2003 to 2005
$147k
NCI NIH HHS CA46592NCI NIH HHS P30 CA046592NIAMS NIH HHS AR20557NIA NIH HHS P30 AG013283NIA NIH HHS P30AG013283NICHD NIH HHS F32 HD045066NICHD NIH HHS F32HD045066NICHD NIH HHS R01 HD034283NICHD NIH HHS R01 HD036404NICHD NIH HHS R01HD34283NICHD NIH HHS R01HD36404NICHD NIH HHS R37 HD030428NICHD NIH HHS R37HD30428NIDCR NIH HHS K12 DE014528NIDCR NIH HHS K12DE014528NIDDK NIH HHS DK34933NIDDK NIH HHS P30 DK034933NIMH NIH HHS R01 MH081187NIMH NIH HHS R01MH081187
6 · The paper itself

Abstract

RNA interference (RNAi) is a powerful strategy for studying the phenotypic consequences of reduced gene expression levels in model systems. To develop a method for the rapid characterization of the developmental consequences of gene dysregulation, we tested the use of RNAi for "transient transgenic" knockdown of mRNA in mouse embryos. These methods included lentiviral infection as well as transposition using the Sleeping Beauty (SB) and PiggyBac (PB) transposable element systems. This approach can be useful for phenotypic validation of putative mutant loci, as we demonstrate by confirming that knockdown of Prdm16 phenocopies the ENU-induced cleft palate (CP) mutant, csp1. This strategy is attractive as an alternative to gene targeting in embryonic stem cells, as it is simple and yields phenotypic information in a matter of weeks. Of the three methodologies tested, the PB transposon system produced high numbers of transgenic embryos with the expected phenotype, demonstrating its utility as a screening method.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBase SequenceCleft PalateDevelopmental BiologyDisease Models, AnimalDNA-Binding ProteinsDNA Transposable ElementsEmbryonic Stem CellsLentivirusMiceMice, KnockoutMice, TransgenicMolecular Sequence DataMutationOligonucleotide Array Sequence AnalysisDNA-Binding ProteinsDNA Transposable ElementsPrdm16 protein, mouseTranscription Factors

Identifiers

PMID21179568
PMCPMC3002952
OpenAlexW2161063308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.